Inhibitory circuits in human dysplastic tissue

Epilepsia

Volumn 41, Issue SUPPL. 6, 2000, Pages

  Spreafico, R ^a   Tassi, L ^b   Colombo, N ^b   Bramerio, M ^b   Galli, C ^b   Garbelli, R ^a   Ferrario, A ^a   Lo Russo, G ^b   Munari, C ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Cortex; Epilepsy; GABA; Immunocytochemistry; Neuropathology

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; PARVALBUMIN;

ADULT; BRAIN CORTEX; CASE REPORT; CONFERENCE PAPER; DYSPLASIA; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTOGENESIS; FEMALE; GABAERGIC SYSTEM; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0033811079     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb01576.x     Document Type: Conference Paper

References (38)

1. Excitation and inhibition in epilepsy
2. Epilepsy and the too-well-connected brain
3. Functional explorations of the human epileptic brain and their therapeutic implications
4. Lesional surgery
5. Stereo-EEG of interictal and ictal electrical activity of a histologically proved heterotopic gray matter associated with partial epilepsy
6. Focal neuronal migration disorders and intractable partial epilepsy: A study of 30 patients
7. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results
8. Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus
9. Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci
10. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia
11. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy
12. Cerebral cortical dysplasia associated with pediatric epilepsy: Review of neuropathologic features and proposal for a grading system
13. Immunocytochemical investigation on dysplastic human tissue from epileptic patients
14. Cortical dysplasia: An immunocytochemical study of three patients
15. Neuronal migration disorders and epilepsy: A morphological analysis of three surgically treated patients
16. Taylor's cortical dysplasia: A confocal and ultrastructural immunohistochemical study
17. Alterations of GABA-mediated synaptic transmission in human epilepsy
18. GABA neurons in seizure disorders: A review of immunocytochemical studies
19. Selective changes in the microorganization of the human epileptogenic neocortex revealed by parvalbumin immunoreactivity
20. Inhibitory neurons in the human epileptogenic temporal neocortex: An immunocytochemical study
21. Hippocampal GABA transporter function in temporal-lobe epilepsy
22. Carrier-mediated release of neurotransmitters
23. GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex
24. GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex
25. Neuronal and glial localization of GAT-1, a high-affinity -aminobutyric acid plasma membrane transporter, in human cerebral cortex: With a note on its distribution in monkey cortex
26. Chandelier cell axons are immunoreactive for GAT-1 in the human neocortex
27. Synapses, axonal and dendritic patterns of GABA-immunoreactive neurons in human cerebral cortex
28. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex
29. Calretinin-immunoreactive neurons in the primary visual cortex of dolphin and human brains
30. Neocortical neuronal diversity: Chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules
31. Chandelier cells and epilepsy
32. Focal dysplasia of the cerebral cortex in epilepsy
33. Cortical rearrangement in the epileptogenic focal dysplasia
34. Outcome with respect to epileptic seizures
35. Abnormal cytoarchitecture of cortical dysplasia verified by immunohistochemistry
36. A study of SMI 32-stained pyramidal cells, parvalbumin-immunoreactive chandelier cells, and presumptive thalamocortical axons in the human temporal cortex
37. Malformations of cortical development: Clinical-neuroradiologic correlations in 38 patients
38. MRI in focal cortical dysplasia